Berberine: a potential phytochemical with multispectrum therapeutic activities
- PMID: 20836620
- DOI: 10.1517/13543784.2010.517745
Berberine: a potential phytochemical with multispectrum therapeutic activities
Abstract
Importance of the field: The use of traditional medicines of natural origin is being encouraged for the treatment of chronic disorders, as synthetic drugs in such cases may cause unpredictable adverse effects. Berberine, a traditional plant alkaloid, is used in Ayurvedic and Chinese medicine for its antimicrobial and antiprotozoal properties. Interestingly, current clinical research on berberine has revealed its various pharmacological properties and multi-spectrum therapeutic applications.
Areas covered in this review: An extensive search in three electronic databases (Unbound Medline, PubMed and ScienceDirect) and internet search engines (Scirus and Google Scholar) were used to identify the clinical studies on berberine, without any time constraints. This review elaborates the recent studies which reveal that with time, the drug has evolved with superior therapeutic activities. In addition, this review will also attract the attention of formulation scientists towards the issues and challenges associated in its drug delivery and the probable approaches that may be explored to help patients reap the maximum benefit of this potentially useful drug.
What the reader will gain: A relatively large number of studies discussed here have revealed the possible areas where this phytochemical constituent can exhibit its therapeutic activities in the treatment of chronic ailments or diseases including diabetes, cancer, depression, hypertension and hypercholesterolemia.
Take home message: The potential of the drug remains to be harvested by designing a suitable formulation that could overcome its inherent low bioavailability.
Similar articles
-
Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.Phytother Res. 2010 Mar;24(3):317-24. doi: 10.1002/ptr.2968. Phytother Res. 2010. PMID: 19998323 Review.
-
Berberine.Altern Med Rev. 2000 Apr;5(2):175-7. Altern Med Rev. 2000. PMID: 10767672
-
Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.J Ethnopharmacol. 2009 Oct 29;126(1):5-17. doi: 10.1016/j.jep.2009.08.009. Epub 2009 Aug 15. J Ethnopharmacol. 2009. PMID: 19686830 Review.
-
Current knowledge and pharmacological profile of berberine: An update.Eur J Pharmacol. 2015 Aug 15;761:288-97. doi: 10.1016/j.ejphar.2015.05.068. Epub 2015 Jun 16. Eur J Pharmacol. 2015. PMID: 26092760 Review.
-
The natural product berberine is a human prolyl oligopeptidase inhibitor.ChemMedChem. 2007 Mar;2(3):354-9. doi: 10.1002/cmdc.200600303. ChemMedChem. 2007. PMID: 17295371
Cited by
-
Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer's disease.ScientificWorldJournal. 2012;2012:823201. doi: 10.1100/2012/823201. Epub 2012 Jan 4. ScientificWorldJournal. 2012. PMID: 22262957 Free PMC article.
-
Review of Medicinal Plants Traditionally Used to Treat Diarrhea by the People in the Amhara Region of Ethiopia.Evid Based Complement Alternat Med. 2023 Nov 25;2023:8173543. doi: 10.1155/2023/8173543. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 38044982 Free PMC article. Review.
-
The Efficacy of Psychological Care and Chinese Herbal Decoction in Postoperative Chemotherapy Patients with Endometrial Cancer.J Healthc Eng. 2022 Feb 18;2022:5700637. doi: 10.1155/2022/5700637. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Jul 26;2023:9867956. doi: 10.1155/2023/9867956. PMID: 35222888 Free PMC article. Retracted. Clinical Trial.
-
Development of Natural Polysaccharide-Based Nanoparticles of Berberine to Enhance Oral Bioavailability: Formulation, Optimization, Ex Vivo, and In Vivo Assessment.Polymers (Basel). 2021 Nov 5;13(21):3833. doi: 10.3390/polym13213833. Polymers (Basel). 2021. PMID: 34771389 Free PMC article.
-
Reversal of multidrug resistance by 5,5'-dimethoxylariciresinol-4-O-β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX.Indian J Pharmacol. 2013 Nov-Dec;45(6):597-602. doi: 10.4103/0253-7613.121371. Indian J Pharmacol. 2013. PMID: 24347768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials